Publication | Closed Access

Pentoxifylline as a modulator of anticancer drug doxorubicin. Part II: Reduction of doxorubicin DNA binding and alleviation of its biological effects

Medicinal ChemistryHealth SciencesMedicineDoxorubicin Dna BindingAnticancer Drug DoxorubicinAnti-cancer AgentPharmacologyRadiation OncologyPharmaceutical ChemistryDrug DiscoveryPart IiDrug Resistance